| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |